We anticipate that altered expression of miR-193b in breast tissue has a downstream effect on a network of genes (including DDAH1) that are critical for tumour pathology; further analysis of this miRNA-regulatory network is ongoing in our laboratory. The gene discussed is DDAH1; the disease is neoplasm.